Please login to the form below

Not currently logged in
Email:
Password:

Insmed

This page shows the latest Insmed news and features for those working in and with pharma, biotech and healthcare.

Features Archive listing

Insmed’s Olaf Bartsch tells PME about the US biotech’s year of progress. .

Latest news

  • Survival strategy

    Examples include Merck's $130m acquisition of Insmed's biologic facilities and pipeline, Mylan's deal with Biocon in 2009, Pfizer's $350m deal with Biocon for insulin biosimilars in October

  • Biogen Idec gains ALS drug

    In addition, under an FDA-approved programme, a limited number of people with ALS receive Insmed's Iplex, although the drug has not been granted marketing approval for the indication.

  • Biologics at forefront

    Novartis/Sandoz is already a major player in biosimilars while, last year, Merck acquired Insmed's portfolio of follow-on biologics for $130m in cash.

  • The Pump House

    Hepatitis. China. Mecasermin rinfabate. Iplex (Insmed). Growth disorders. US. Methylphenidate. Methylin Chewable Tablets (Alliant Pharmaceuticals).

More from news
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Significant figures Significant figures

    Significant figures. Insmed’s Olaf Bartsch tells PME about the US biotech’s year of progress. ... However, Insmed believes ALIS “has the opportunity to dramatically improve the treatment of NTM lung disease”.

  • Deal Watch October 2016 Deal Watch October 2016

    In the deal with Insmed the molecule is in phase I and has been licensed for development and commercialisation in an orphan indication to Insmed and AstraZeneca has retained the option ... 160. AstraZeneca (UK). Insmed. Licence. Dipeptidyl peptidase one

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics